Apple Adds Brain-to-Computer Protocol to Its Accessibility Repertoire
Apple Adds Brain-to-Computer Protocol to Its Accessibility Repertoire
By John P. Mello Jr.
May 14, 2025 5:00 AM PT
ADVERTISEMENT
Rubrik Foward 2025: The Future of Cyber Resilience is here
When an attacker comes for your business, will you be ready? Chart your path to cyber resilience and keep your business running. June 4 | Virtual Event | Register Now
Among a raft of upcoming accessibility tools revealed Tuesday, Apple announced a new protocol for brain-to-computer interfaceswithin its Switch Control feature. The protocol allows iOS, iPadOS, and visionOS devices to support an emerging technology that enables users to control their digital hardware without physical movement.
One of the first companies to take advantage of the new protocol will be New York-based Synchron. “This marks a major milestone in accessibility and neurotechnology, where users implanted with Synchron’s BCI can control iPhone, iPad, and Apple Vision Pro directly with their thoughts without the need for physical movement or voice commands,” the company said in a statement.
It added that Synchron’s BCI system will seamlessly integrate with Apple’s built-in accessibility features, including Switch Control, giving users an intuitive way to use their devices and laying the foundation for a new generation of cognitive input technologies.
“This marks a defining moment for human-device interaction,” Synchron CEO and Co-Founder Tom Oxley said in a statement. “BCI is more than an accessibility tool, it’s a next-generation interface layer.”
“Apple is helping to pioneer a new interface paradigm, where brain signals are formally recognized alongside touch, voice, and typing,” he continued. “With BCI recognized as a native input for Apple devices, there are new possibilities for people living with paralysis and beyond.”
BCI Validation
Tetiana Aleksandrova, CEO of Subsense, a biotechnology company in Covina, Calif., specializing in non-surgical bidirectional brain-computer interfaces, maintained Apple’s announcement marks a powerful signal showing the evolution of BCI. “I see it as Apple throwing open the gates — a single-stroke move that invites clinically-validated BCIs like Synchron’s Stentrode to plug straight into a billion-device ecosystem,” she told TechNewsWorld.
“For patients, it means ‘mind-to-message’ control without middleware,” she said. “For the BCI industry, it’s a public stamp that neural input is ready for prime time — and yes, that’s a thrilling milestone for all of us building the next generation of non-surgical systems. It’s a shift, moving BCI from a nascent technology to more mainstream applications.”
Aleksandrova maintained that BCI fits nicely into Apple’s overall accessibility strategy.
“Apple’s playbook is to solve an extreme edge case, polish the UX until it’s invisible, then let the rest of the world adopt it,” she explained. “VoiceOver paved the way for Siri. Switch Control turned into Face Gestures. BCI support is the natural next rung on that ladder. Accessibility isn’t a side quest for Apple — it’s the R and D lab that future-proofs their core UI.”
“Apple devices put unlimited information at users’ fingertips,” she added, “but for people with disabilities from TBI or ALS, full access can be out of reach. BCI technology helps bridge that gap, giving them a way to control and interact with their devices using only their brain activity.”
Analysts See BCI as Long-Term Technology
Apple’s embrace of BCI is significant, but its impact still lies in the future, noted Will Kerwin, technology equity analyst with Morningstar Research Services in Chicago. “While a particularly cool announcement, we think this type of feature is a long way away from full commercialization and not material to investors in Apple at this point,” he told TechNewsWorld.
Kerwin pointed out that Synchron’s Stentrode BCI currently only has a sample size of 10 people.
“Long-term, yes, this technology could have huge implications for how humans interact with technology, and we see it as an adjacency to AI, where generative AI could help improve the interface and ability for humans to communicate via the implant,” he said. “But again, we see this as an extremely long-term journey in its nascent days.”
According to the Wall Street Journal, FDA approval of Synchron’s Stenrode technology is years away. The procedure involves implanting a stent-mounted electrode array into a blood vessel in the brain, so there’s no need for open brain surgery.
“Some companies in the BCI space are focused on cortical control of prosthetics, others on cognitive enhancement or memory restoration,” Synchron spokesperson Kimberly Ha told TechNewsWorld. “What sets us apart is our focus on scalability and safety. By implanting via the blood vessels, we avoid open brain surgery, making our approach more feasible for potentially broader medical use.”
Solving the BCI Scalability Problem
Ha acknowledged that there are significant challenges to the broad adoption of BCI. “Scalability is one of the biggest,” she said.
“Historically, many BCI systems have required open brain surgery, which presents serious risks and limits to who can access the technology,” she explained. “It’s simply not scalable for widespread clinical or consumer use.”
“Synchron takes a fundamentally different approach,” she continued. “Our Stentrode device is implanted via the blood vessels, similar to a heart stent, avoiding the need to open the skull or directly penetrate brain tissue. This makes the procedure far less invasive, more accessible to patients, and better suited to real-world clinical deployment.”
There are also challenges to developing the BCI apps themselves. “The biggest challenge in developing BCI applications is the trade-off between signal quality and accessibility,” Aleksandrova explained. “While a directly implanted BCI offers strong brain signals, surgery is risky. With non-invasive systems, the resolution is poor.”
Her company, Subsense, is trying to offer the best of both worlds through the use of nanoparticles, which can provide bidirectional communication by crossing the blood-brain barrier to interact with neurons and transmit signals.
Thought-Driven Interfaces for New Use Cases
Ha noted that in addition to medical applications, BCI could be used for hands-free device control across all types of digital platforms, neuroadaptive gaming, or immersive XR experiences.
“BCI opens doors to applications in mental wellness, communication tools, and cognitive enhancement,” Aleksandrova added.
“You’ll fire off texts, browse AR screens, or write code just by thinking,” she said. “You’ll slip seamlessly into a drone or handle a surgical robot as though it were your own hand, and nudge your smart home with a silent impulse that dims the lights when focus peaks.”
“Entertainment will read the room inside your head — dialing a game’s difficulty or a film’s plot to match your mood — while always-on neural metrics warn of fatigue, migraines, or anxiety hours before you notice and even surface names or ideas when your memory stalls,” she predicted. “Your unique brainwave ‘fingerprint’ will replace passwords, and researchers are already sketching ways to preserve those patterns so our minds can outlast failing bodies.”
“I’m genuinely proud of Synchron and Apple for opening this door,” she said.
John P. Mello Jr. has been an ECT News Network reporter since 2003. His areas of focus include cybersecurity, IT issues, privacy, e-commerce, social media, artificial intelligence, big data and consumer electronics. He has written and edited for numerous publications, including the Boston Business Journal, the Boston Phoenix, Megapixel.Net and Government Security News. Email John.
Leave a Comment
Click here to cancel reply.
Please sign in to post or reply to a comment. New users create a free account.
More by John P. Mello Jr.
view all
More in Science
#apple #adds #braintocomputer #protocol #its
Apple Adds Brain-to-Computer Protocol to Its Accessibility Repertoire
Apple Adds Brain-to-Computer Protocol to Its Accessibility Repertoire
By John P. Mello Jr.
May 14, 2025 5:00 AM PT
ADVERTISEMENT
Rubrik Foward 2025: The Future of Cyber Resilience is here
When an attacker comes for your business, will you be ready? Chart your path to cyber resilience and keep your business running. June 4 | Virtual Event | Register Now
Among a raft of upcoming accessibility tools revealed Tuesday, Apple announced a new protocol for brain-to-computer interfaceswithin its Switch Control feature. The protocol allows iOS, iPadOS, and visionOS devices to support an emerging technology that enables users to control their digital hardware without physical movement.
One of the first companies to take advantage of the new protocol will be New York-based Synchron. “This marks a major milestone in accessibility and neurotechnology, where users implanted with Synchron’s BCI can control iPhone, iPad, and Apple Vision Pro directly with their thoughts without the need for physical movement or voice commands,” the company said in a statement.
It added that Synchron’s BCI system will seamlessly integrate with Apple’s built-in accessibility features, including Switch Control, giving users an intuitive way to use their devices and laying the foundation for a new generation of cognitive input technologies.
“This marks a defining moment for human-device interaction,” Synchron CEO and Co-Founder Tom Oxley said in a statement. “BCI is more than an accessibility tool, it’s a next-generation interface layer.”
“Apple is helping to pioneer a new interface paradigm, where brain signals are formally recognized alongside touch, voice, and typing,” he continued. “With BCI recognized as a native input for Apple devices, there are new possibilities for people living with paralysis and beyond.”
BCI Validation
Tetiana Aleksandrova, CEO of Subsense, a biotechnology company in Covina, Calif., specializing in non-surgical bidirectional brain-computer interfaces, maintained Apple’s announcement marks a powerful signal showing the evolution of BCI. “I see it as Apple throwing open the gates — a single-stroke move that invites clinically-validated BCIs like Synchron’s Stentrode to plug straight into a billion-device ecosystem,” she told TechNewsWorld.
“For patients, it means ‘mind-to-message’ control without middleware,” she said. “For the BCI industry, it’s a public stamp that neural input is ready for prime time — and yes, that’s a thrilling milestone for all of us building the next generation of non-surgical systems. It’s a shift, moving BCI from a nascent technology to more mainstream applications.”
Aleksandrova maintained that BCI fits nicely into Apple’s overall accessibility strategy.
“Apple’s playbook is to solve an extreme edge case, polish the UX until it’s invisible, then let the rest of the world adopt it,” she explained. “VoiceOver paved the way for Siri. Switch Control turned into Face Gestures. BCI support is the natural next rung on that ladder. Accessibility isn’t a side quest for Apple — it’s the R and D lab that future-proofs their core UI.”
“Apple devices put unlimited information at users’ fingertips,” she added, “but for people with disabilities from TBI or ALS, full access can be out of reach. BCI technology helps bridge that gap, giving them a way to control and interact with their devices using only their brain activity.”
Analysts See BCI as Long-Term Technology
Apple’s embrace of BCI is significant, but its impact still lies in the future, noted Will Kerwin, technology equity analyst with Morningstar Research Services in Chicago. “While a particularly cool announcement, we think this type of feature is a long way away from full commercialization and not material to investors in Apple at this point,” he told TechNewsWorld.
Kerwin pointed out that Synchron’s Stentrode BCI currently only has a sample size of 10 people.
“Long-term, yes, this technology could have huge implications for how humans interact with technology, and we see it as an adjacency to AI, where generative AI could help improve the interface and ability for humans to communicate via the implant,” he said. “But again, we see this as an extremely long-term journey in its nascent days.”
According to the Wall Street Journal, FDA approval of Synchron’s Stenrode technology is years away. The procedure involves implanting a stent-mounted electrode array into a blood vessel in the brain, so there’s no need for open brain surgery.
“Some companies in the BCI space are focused on cortical control of prosthetics, others on cognitive enhancement or memory restoration,” Synchron spokesperson Kimberly Ha told TechNewsWorld. “What sets us apart is our focus on scalability and safety. By implanting via the blood vessels, we avoid open brain surgery, making our approach more feasible for potentially broader medical use.”
Solving the BCI Scalability Problem
Ha acknowledged that there are significant challenges to the broad adoption of BCI. “Scalability is one of the biggest,” she said.
“Historically, many BCI systems have required open brain surgery, which presents serious risks and limits to who can access the technology,” she explained. “It’s simply not scalable for widespread clinical or consumer use.”
“Synchron takes a fundamentally different approach,” she continued. “Our Stentrode device is implanted via the blood vessels, similar to a heart stent, avoiding the need to open the skull or directly penetrate brain tissue. This makes the procedure far less invasive, more accessible to patients, and better suited to real-world clinical deployment.”
There are also challenges to developing the BCI apps themselves. “The biggest challenge in developing BCI applications is the trade-off between signal quality and accessibility,” Aleksandrova explained. “While a directly implanted BCI offers strong brain signals, surgery is risky. With non-invasive systems, the resolution is poor.”
Her company, Subsense, is trying to offer the best of both worlds through the use of nanoparticles, which can provide bidirectional communication by crossing the blood-brain barrier to interact with neurons and transmit signals.
Thought-Driven Interfaces for New Use Cases
Ha noted that in addition to medical applications, BCI could be used for hands-free device control across all types of digital platforms, neuroadaptive gaming, or immersive XR experiences.
“BCI opens doors to applications in mental wellness, communication tools, and cognitive enhancement,” Aleksandrova added.
“You’ll fire off texts, browse AR screens, or write code just by thinking,” she said. “You’ll slip seamlessly into a drone or handle a surgical robot as though it were your own hand, and nudge your smart home with a silent impulse that dims the lights when focus peaks.”
“Entertainment will read the room inside your head — dialing a game’s difficulty or a film’s plot to match your mood — while always-on neural metrics warn of fatigue, migraines, or anxiety hours before you notice and even surface names or ideas when your memory stalls,” she predicted. “Your unique brainwave ‘fingerprint’ will replace passwords, and researchers are already sketching ways to preserve those patterns so our minds can outlast failing bodies.”
“I’m genuinely proud of Synchron and Apple for opening this door,” she said.
John P. Mello Jr. has been an ECT News Network reporter since 2003. His areas of focus include cybersecurity, IT issues, privacy, e-commerce, social media, artificial intelligence, big data and consumer electronics. He has written and edited for numerous publications, including the Boston Business Journal, the Boston Phoenix, Megapixel.Net and Government Security News. Email John.
Leave a Comment
Click here to cancel reply.
Please sign in to post or reply to a comment. New users create a free account.
More by John P. Mello Jr.
view all
More in Science
#apple #adds #braintocomputer #protocol #its
·37 Visualizações